| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $36.44B | +1.2% |
| Cost of Revenue | $22.18B | -0.3% |
| Gross Profit | $14.26B | +3.6% |
| R&D Expense | $400.0M | +5.3% |
| SG&A Expense | $7.44B | -7.0% |
| Operating Income | $6.34B | +15.3% |
| Interest Expense | $508.0M | -7.6% |
| Pre-tax Income | $6.26B | +6.5% |
| Income Tax | $1.47B |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $3.87B | +6.6% |
| Inventory | $3.83B | +5.9% |
| Current Assets | $13.24B | +13.2% |
| Total Assets | $68.50B | -4.1% |
| Current Liabilities | $19.55B | +2.8% |
| Long-term Debt | $15.66B | -7.2% |
| Total Liabilities | $41.54B | -3.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.91B | +4.2% |
| Capital Expenditures | $1.39B | +24.7% |
| Investing Cash Flow | $526.0M | -81.3% |
| Financing Cash Flow | -$5.78B | +23.5% |
| Free Cash Flow | $3.52B | -2.2% |
| -4.4% |
| Net Income | $4.61B | -7.0% |
| EPS (Basic) | $3.44 | -5.5% |
| EPS (Diluted) | $3.42 | -5.5% |
| Stockholders' Equity |
| $26.93B |
| -4.9% |